Linked Life Data

18711172

Source:http://linkedlifedata.com/resource/pubmed/id/18711172

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
29
pubmed:dateCreated
2008-10-9
pubmed:abstractText
Adjuvant chemotherapy for breast cancer (BC) may be associated with increased rates of bone loss and decreased bone mineral density (BMD) and may lead to premature osteoporosis and increased fracture risk. We examined whether zoledronic acid (ZA) prevents bone loss in premenopausal women receiving chemotherapy for early-stage BC.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-10098755, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-10469749, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-11454877, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-14530912, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-15639680, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-15767532, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-15769994, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-16135834, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-16145047, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-16204691, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-16636120, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-16731427, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-17047022, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-17159195, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-17476007, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-17577014, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-2310683, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-3384952, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-7696835, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-8622093, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-8634613, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-8889854, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-9052418, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-9060533, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-9193325, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-9474245, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-9568781, http://linkedlifedata.com/resource/pubmed/commentcorrection/18711172-9586668
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
10
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4739-45
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer.
pubmed:affiliation
Department of Medicine, Herbert Irving Comprehensive Cancer Center, College of Physicians andSurgeons, Columbia University, New York, NY 10032, USA. dlh23@columbia.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III, Research Support, N.I.H., Extramural